Pharma Marketing News
PMN Home | Advertising Information | FAQs
About Us | Contact Us | Privacy Policy
Subscribe Glossary
Pharma Marketing Blog Pharmaguy Audio Podcasts Event Calendar PReader Surveys

Share |

New Privacy Rules in Economic Stimulus Law
Will They Restrict Certain Pharmaceutical Marketing Practices?

No Rx DataBeefed-up patient privacy protections in the recently enacted economic stimulus package are expected to place significant new restrictions on how some players in the pharmaceutical supply chain, including chain drugstores and PBMs, gather and distribute prescribing information to pharmaceutical firms for what critics claim is the purpose of marketing drugs.

This article reviews the medical privacy restrictions included in the American Recovery and Reinvestment Act, which President Obama signed into law on Feb. 17, 2009, and discusses the impact these restrictions might have on pharmaceutical marketing.

Topic headings include:

  • Limits Placed on HIPAA Exclusions
  • Could Curtail Marketing
  • Critics Warn That Rx Data Are Still Accessible
  • Ensuring That Privacy Doesn't Hamper HIT

Read this article now. It's FREE...

Download PDF file

PMN83-04
Issue: Vol. 8, No. 3: March 2009
Word Count: 1333

Find other articles in related Topic Areas:

Vol 8, #3 Contents








Contact Information
Editor
Pharma Marketing News

Pharma Marketing News | Subscribe | Industry Insights | Podcasts | Pharmaguy | Blog
Surveys | Glossary | Conference Calendar | Advertising Information | FAQs | About Us | Privacy Policy

© 2014. Pharma Marketing Network. All rights reserved.